Abstract
An oxovanadium complex of quercetin (2), exhibits highly potent insulin-enhancing activity in streptozotocin-induced diabetic mice. It also mimics mitogenic potential of insulin as evaluated by [H(3)]thymidine uptake assay making an effective, orally active insulin-enhancing agent for the treatment of both type 1 and type 2 diabetes without any noticeable toxic effects.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Hypoglycemic Agents / chemical synthesis*
-
Hypoglycemic Agents / chemistry
-
Hypoglycemic Agents / pharmacology
-
Magnetics
-
Male
-
Mice
-
Mice, Inbred BALB C
-
Mitogens / pharmacology
-
Pyrones / pharmacology
-
Quercetin / chemical synthesis*
-
Quercetin / pharmacology
-
Vanadates / chemical synthesis*
-
Vanadates / pharmacology
Substances
-
Hypoglycemic Agents
-
Mitogens
-
Pyrones
-
oxovanadium IV
-
bis(maltolato)oxovanadium(IV)
-
Vanadates
-
Quercetin